Portfolio programmes

AI Clinics for Venture Portfolios

Confidential AI clinics for venture portfolio founders: a short intake, a working session per company, specific next steps, and an anonymised view for the fund.

Direct answer

Direct answer: Venture portfolio clinics

Founders in one venture portfolio rarely share the same AI problem. One is deciding whether to build on a model provider, another has a demo that will not survive real customers, and a third is being asked about AI by investors without needing it yet. A clinic gives each founder a confidential working session on their own question and a written next step, and gives the fund an anonymised picture of where its companies actually stand.

The question

“Our founders have very different AI needs. How can one programme triage those needs and produce company-specific next steps?”

Who it is for

Platform, portfolio-support, and operating teams at venture capital funds.

What you leave with

Portfolio intake, company clinic outputs, and anonymised programme-level findings.

  • 01 A one-page intake per company, completed by the founder before the clinic
  • 02 A confidential clinic note per company: the question, the options discussed, the recommended next step, and what would change the recommendation
  • 03 A triage category per company: education, validation, implementation, or no intervention yet
  • 04 An anonymised fund-level summary of recurring technical questions, gaps, and requests

How it runs

Format, method, and preparation

Duration
Typically 45–60 minutes per company, run across one or more clinic days, with optional follow-up office hours
Delivery
Remote by default; in person in the UK for a portfolio day
Participants
Founder or CEO and, where useful, the company’s technical lead
01

Founder intake

Each founder states the AI decision in front of them, the product context, the data they hold, and who on the team would own the work.

02

Clinic session

Work through the decision: what is known, what is assumed, what could be tested cheaply, and what should not be built yet.

03

Written next step

Each company receives a short note with one recommended next action and the evidence that would change it.

04

Fund summary

The fund receives anonymised patterns across companies, so platform support can respond to real demand rather than guesses.

Useful to have ready

  • →A platform or portfolio owner at the fund to coordinate invitations
  • →Founders who opt in and complete the intake beforehand
  • →An agreed confidentiality rule for what the fund sees

Evidence

What this draws on

Founder record

Six companies founded, 2008–2024

Kwippy, Jaja.tv, Octo.ai, ExpressMOJO, Boom, and Neul Labs, spanning social software, interactive media, ML and analytics, logistics, blockchain infrastructure, and applied AI. Advisory and investment records are not counted as founded companies.

Read more →
Founder record

Boom investor commitments

Boom recorded more than $2.5M in investor commitments and commercial letters of intent. That is not money raised, recognised revenue, or production adoption.

Read more →
Founder programme participant

Westerwelle Young Founders Programme (2019)

Selected as a fellow of the Westerwelle Foundation’s Young Founders Programme.

Read more →

Scope and limits

What this is not

  • —Clinic notes belong to each company. The fund sees an anonymised summary unless a company chooses to share its note.
  • —Clinics do not assess whether a company is a good investment, and they are not valuation, legal, or regulated investment advice.
  • —A clinic is a portfolio-wide programme. A single company that needs its own adoption engagement is better served by a separately scoped piece of work.

If the need is different

Common questions

Answers before you commission

What happens in a VC portfolio AI clinic?+

Each founder brings one AI decision, such as whether to build or buy, how to evaluate a feature before launch, or how to answer investor questions about AI. We work through it in a confidential session, and the founder leaves with one written next step.

Can founders at very different stages join the same programme?+

Yes. Because each session starts from the company’s own intake, a pre-product founder and a scaling company can both get a relevant outcome. Group sessions, if used, are split by stage or problem.

Does the fund see what each founder said?+

No, not by default. The fund receives an anonymised summary of patterns. Company notes are shared only if the company agrees.

Can clinics continue as office hours?+

Yes. Some funds follow a clinic day with periodic office hours for companies whose triage outcome was education or validation.

Related

Next step

Describe your audience and decision

A short written brief is enough to establish fit. I reply personally, and say plainly when the work belongs elsewhere or is not worth commissioning.

Portfolio or cohort programme: what to include

  • →Sponsor organisation and programme owner
  • →Number, stage, and sector of participating companies
  • →What companies are asking for
  • →Desired outputs for the sponsor and for each company
  • →Format: clinics, cohort sessions, office hours, or review
  • →Timing and duration
  • →Budget range and who pays
  • →Confidentiality expectations between companies